ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974

Rays Of Hope Candlelight Vigil Scheduled For Oct. 6.

September 8, 2000

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

House Committee To Examine Personal Genetic Test Kits

May 21, 2010

In the Cancer Centers: Margaret Kripke of M.D. Anderson to Retire in 2007.

June 16, 2006

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

December 20, 1974